R Christopher Doiron1, Melanie Jaeger2, Christopher M Booth3, Xuejiao Wei4, D Robert Siemens5. 1. Department of Urology. 2. Department of Anesthesiology and Perioperative Medicine. 3. Department of Oncology;; Public Health Sciences;; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute; Queen's University, Kingston, ON, Canada. 4. Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute; Queen's University, Kingston, ON, Canada. 5. Department of Urology;; Department of Oncology;; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute; Queen's University, Kingston, ON, Canada.
Abstract
INTRODUCTION: Thoracic epidural analgesia (TEA) is commonly used to manage postoperative pain and facilitate early mobilization after major intra-abdominal surgery. Evidence also suggests that regional anesthesia/analgesia may be associated with improved survival after cancer surgery. Here, we describe factors associated with TEA at the time of radical cystectomy (RC) for bladder cancer and its association with both short- and long-term outcomes in routine clinical practice. METHODS: All patients undergoing RC in the province of Ontario between 2004 and 2008 were identified using the Ontario Cancer Registry (OCR). Modified Poisson regression was used to describe factors associated with epidural use, while a Cox proportional hazards model describes associations between survival and TEA use. RESULTS: Over the five-year study period, 1628 patients were identified as receiving RC, 54% (n=887) of whom received TEA. Greater anesthesiologist volume (lowest volume providers relative risk [RR] 0.85, 95% confidence interval [CI] 0.75-0.96) and male sex (female sex RR 0.89, 95% CI 0.79-0.99) were independently associated with greater use of TEA. TEA use was not associated with improved short-term outcomes. In multivariable analysis, TEA was not associated with cancer-specific survival (hazard ratio [HR] 1.02, 95% CI 0.87-1.19; p=0.804) or overall survival (HR 0.91, 95% CI 0.80-1.03; p=0.136). CONCLUSIONS: In routine clinical practice, 54% of RC patients received TEA and its use was associated with anesthesiologist provider volume. After controlling for patient, disease and provider variables, we were unable to demonstrate any effect on either short- or long-term outcomes at the time of RC.
INTRODUCTION: Thoracic epidural analgesia (TEA) is commonly used to manage postoperative pain and facilitate early mobilization after major intra-abdominal surgery. Evidence also suggests that regional anesthesia/analgesia may be associated with improved survival after cancer surgery. Here, we describe factors associated with TEA at the time of radical cystectomy (RC) for bladder cancer and its association with both short- and long-term outcomes in routine clinical practice. METHODS: All patients undergoing RC in the province of Ontario between 2004 and 2008 were identified using the Ontario Cancer Registry (OCR). Modified Poisson regression was used to describe factors associated with epidural use, while a Cox proportional hazards model describes associations between survival and TEA use. RESULTS: Over the five-year study period, 1628 patients were identified as receiving RC, 54% (n=887) of whom received TEA. Greater anesthesiologist volume (lowest volume providers relative risk [RR] 0.85, 95% confidence interval [CI] 0.75-0.96) and male sex (female sex RR 0.89, 95% CI 0.79-0.99) were independently associated with greater use of TEA. TEA use was not associated with improved short-term outcomes. In multivariable analysis, TEA was not associated with cancer-specific survival (hazard ratio [HR] 1.02, 95% CI 0.87-1.19; p=0.804) or overall survival (HR 0.91, 95% CI 0.80-1.03; p=0.136). CONCLUSIONS: In routine clinical practice, 54% of RC patients received TEA and its use was associated with anesthesiologist provider volume. After controlling for patient, disease and provider variables, we were unable to demonstrate any effect on either short- or long-term outcomes at the time of RC.
Authors: Michael J Leveridge; D Robert Siemens; William J Mackillop; Yingwei Peng; Ian F Tannock; David M Berman; Christopher M Booth Journal: Urology Date: 2015-02-07 Impact factor: 2.649
Authors: Toby N Weingarten; Ashley M Taccolini; Samuel T Ahle; Kelsey R Dietz; Shaun S Dowd; Igor Frank; Stephen A Boorjian; Prabin Thapa; Andrew C Hanson; Darrell R Schroeder; Juraj Sprung Journal: Can J Anaesth Date: 2016-02-05 Impact factor: 5.063
Authors: Aristomenis K Exadaktylos; Donal J Buggy; Denis C Moriarty; Edward Mascha; Daniel I Sessler Journal: Anesthesiology Date: 2006-10 Impact factor: 7.892
Authors: Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens Journal: Can Urol Assoc J Date: 2016-02-08 Impact factor: 1.862
Authors: Rose Christopherson; Kenneth E James; Mara Tableman; Prudence Marshall; Frank E Johnson Journal: Anesth Analg Date: 2008-07 Impact factor: 5.108
Authors: Brady L Miller; E Jason Abel; Glenn Allen; Jessica R Schumacher; David Jarrard; Tracy Downs; Kyle A Richards Journal: Am J Clin Exp Urol Date: 2020-02-25